AAAAAA
Results: 1-25/68
Authors:
Bauer, S
Stormer, E
Graubaum, HJ
Roots, I
Citation: S. Bauer et al., Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection, J CHROMAT B, 765(1), 2001, pp. 29-35
Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy
Authors:
Brinkmann, U
Roots, I
Eichelbaum, M
Citation: U. Brinkmann et al., Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy, DRUG DISC T, 6(16), 2001, pp. 835-839
Authors:
Kaiser, R
Tremblay, PB
Schmider, J
Henneken, M
Dettling, M
Muller-Oerlinghausen, B
Uebelhack, R
Roots, I
Brockmoller, J
Citation: R. Kaiser et al., Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia, MOL PSYCHI, 6(2), 2001, pp. 179-185
Authors:
Dettling, M
Schaub, RT
Mueller-Oerlinghausen, B
Roots, I
Cascorbi, I
Citation: M. Dettling et al., Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry, PHARMACOGEN, 11(2), 2001, pp. 135-141
Authors:
Meisel, C
Afshar-Kharghan, V
Cascorbi, I
Laule, M
Stangl, V
Felix, SB
Baumann, G
Lopez, JA
Roots, I
Stangl, K
Citation: C. Meisel et al., Role of Kozak sequence polymorphism of platelet glycoprotein Ib alpha as arisk factor for coronary artery disease and catheter interventions, J AM COL C, 38(4), 2001, pp. 1023-1027
Authors:
Schwarz, D
Kisselev, P
Cascorbi, I
Schunck, WH
Roots, I
Citation: D. Schwarz et al., Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants, CARCINOGENE, 22(3), 2001, pp. 453-459
Authors:
Schwarz, D
Kisselev, P
Honeck, H
Cascorbi, I
Schunck, WH
Roots, I
Citation: D. Schwarz et al., Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system, XENOBIOTICA, 31(6), 2001, pp. 345-356
Authors:
Stangl, K
Cascorbi, I
Laule, M
Stangl, V
Meisel, C
Wernecke, KD
Ziemer, S
Baumann, G
Roots, I
Hauner, H
Citation: K. Stangl et al., The beta(3)-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease, METABOLISM, 50(2), 2001, pp. 184-188
Authors:
Meisel, C
Cascorbi, I
Gerloff, T
Stangl, V
Laule, M
Muller, JM
Wernecke, KD
Baumann, G
Roots, I
Stangl, K
Citation: C. Meisel et al., Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levelsand development of coronary artery disease, ATHEROSCLER, 154(3), 2001, pp. 651-658
Authors:
Roots, I
Citation: I. Roots, Conscience and allegiance in seventeenth century England: The political significance of oaths and engagements, HISTORY, 86(283), 2001, pp. 400-401
Authors:
Roots, I
Citation: I. Roots, A revolutionary rogue: Henry Marten and the English Republic, HISTORY, 86(282), 2001, pp. 234-235
Authors:
Roots, I
Citation: I. Roots, Parliament and the Church, 1529-1960, ENGLISH HIS, 116(465), 2001, pp. 214-215
Authors:
Cascorbi, I
Gerloff, T
Johne, A
Meisel, C
Hoffmeyer, S
Schwab, M
Schaeffeler, E
Eichelbaum, M
Brinkmann, U
Roots, I
Citation: I. Cascorbi et al., Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects, CLIN PHARM, 69(3), 2001, pp. 169-174
Authors:
Cascorbi, I
Roots, I
Brockmoller, J
Citation: I. Cascorbi et al., Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: Significantly reduced risk in subjects with NAT110, CANCER RES, 61(13), 2001, pp. 5051-5056
Authors:
Dettling, M
Cascorbi, I
Roots, I
Mueller-Oerlinghausen, B
Citation: M. Dettling et al., Genetic determinants of clozapine-induced agranulocytosis: Recent results of HLA subtyping in a non-Jewish Caucasian sample, ARCH G PSYC, 58(1), 2001, pp. 93-94
Authors:
Kirchheiner, J
Brosen, K
Dahl, ML
Gram, LF
Kasper, S
Roots, I
Sjoqvist, F
Spina, E
Brockmoller, J
Citation: J. Kirchheiner et al., CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages, ACT PSYC SC, 104(3), 2001, pp. 173-192
Authors:
Stormer, E
Brockmoller, J
Roots, I
Schmider, J
Citation: E. Stormer et al., Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro, PSYCHOPHAR, 151(4), 2000, pp. 312-320
Authors:
Meisel, C
Roots, I
Cascorbi, I
Brinkmann, U
Brockmoller, J
Citation: C. Meisel et al., How to manage individualized drug therapy: Application of pharmacogenetic knowledge of drug metabolism and transport, CLIN CH L M, 38(9), 2000, pp. 869-876
Authors:
Budde, K
Glander, P
Bauer, S
Braun, K
Waiser, J
Fritsche, L
Mai, I
Roots, I
Neumayer, HH
Citation: K. Budde et al., Pharmacodynamic monitoring of mycophenolate mofetil, CLIN CH L M, 38(11), 2000, pp. 1213-1216
Authors:
Kaiser, R
Konneker, M
Henneken, M
Dettling, M
Muller-Oerlinghausen, B
Roots, I
Brockmoller, J
Citation: R. Kaiser et al., Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia, MOL PSYCHI, 5(4), 2000, pp. 418-424
Authors:
Marcus, PM
Hayes, RB
Vineis, P
Garcia-Closas, M
Caporaso, NE
Autrup, H
Branch, RA
Brockmoller, J
Ishizaki, T
Karakaya, AE
Ladero, JM
Mommsen, S
Okkels, H
Romkes, M
Roots, I
Rothman, N
Citation: Pm. Marcus et al., Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction, CANC EPID B, 9(5), 2000, pp. 461-467
Authors:
Schwarz, D
Kisselev, P
Schunck, WH
Chernogolov, A
Boidol, W
Cascorbi, I
Roots, I
Citation: D. Schwarz et al., Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity, PHARMACOGEN, 10(6), 2000, pp. 519-530
Authors:
Sprenger, R
Schlagenhaufer, R
Kerb, R
Bruhn, C
Brockmoller, J
Roots, I
Brinkmann, U
Citation: R. Sprenger et al., Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodulargenotype-phenotype correlation, PHARMACOGEN, 10(6), 2000, pp. 557-565
Authors:
Stangl, K
Cascorbi, I
Laule, M
Klein, T
Stangl, V
Rost, S
Wernecke, KD
Felix, SB
Bindereif, A
Baumann, G
Roots, I
Citation: K. Stangl et al., High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease, PHARMACOGEN, 10(2), 2000, pp. 133-140
Authors:
Mai, I
Kruger, H
Budde, K
Johne, A
Brockmoller, J
Neumayer, HH
Roots, I
Citation: I. Mai et al., Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin, INT J CL PH, 38(10), 2000, pp. 500-502